Clinical Trial Update: A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating the combination of BGB-A445 with tislelizumab in patients with select advanced solid tumors, including urothelial carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• BGB-A445
• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Urothelial Carcinoma, Renal Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING